PrintWe cannot find the page you are looking for.
We don't have the page you're looking for
Please select one of the pages below.
.gif)
.gif)
.png){kind=small}
- Top Genentech research exec departing for academia
Reuters - Health Plan Won’t Fuel Big Spending, Report Says
The New York Times - Lilly Invests $150 Million With Venture Firms Seeking New Drug Candidates
Bloomberg - Genzyme Investors Push for Sanofi Bid of $75 a Share
Bloomberg - Sanofi's CEO Viehbacher Pitches Genzyme Investors in New York on Takeover
Bloomberg - Valeant, Biovail to cut 25 pct jobs of combined co
Reuters - Elan gets injunction vs directors, slams investor
Reuters - Sanofi Chief Extends Hand to Bypass Genzyme `Brick Wall'
Bloomberg - U.S. Court Rules Against Obama’s Stem Cell Policy
The New York Times - Takeda Says Lifestyle-Disease Drugs Will Drive Growth
Bloomberg